Hims & Hers Health (HIMS) Change in Cash (2019 - 2026)
Hims & Hers Health (HIMS) reported Change in Cash of -$6.4 million for Q1 2026, down 111.86% on a YoY basis from $53.5 million in Q1 2025, and up 94.58% sequentially from -$117.2 million in Q4 2025.
Hims & Hers Health (HIMS) Change in Cash (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Change in Cash data on file, last reported at -$6.4 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 111.86% year-over-year to -$6.4 million; the trailing twelve-month figure through Mar 2026 stood at -$52.7 million (down 131.2% YoY), and the FY2025 full-year result was $7.2 million, down 94.21% from the prior year.
- Change in Cash advanced to -$6.4 million in Q1 2026, from -$117.2 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $850.0 million in Q2 2025 to a low of -$779.2 million in Q3 2025.
- A 5-year average of $8.8 million and a median of $6.7 million in 2022 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 3433.09% in 2025, while the deepest fall reached 2251.04% in 2025.
- Tracing HIMS's Change in Cash over 5 years: stood at -$11.2 million in 2022, then soared by 445.49% to $38.7 million in 2023, then soared by 42.41% to $55.1 million in 2024, then tumbled by 312.77% to -$117.2 million in 2025, then jumped by 94.58% to -$6.4 million in 2026.
- Business Quant data shows HIMS's Change in Cash at -$6.4 million in Q1 2026, -$117.2 million in Q4 2025, and -$779.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -277.40 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | -6.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.35 Mn |
| Dec 31, 2025 | -117.16 Mn |
| Sep 30, 2025 | -779.17 Mn |
| Jun 30, 2025 | 849.99 Mn |
| Mar 31, 2025 | 53.52 Mn |
| Dec 31, 2024 | 55.07 Mn |
| Sep 30, 2024 | 36.22 Mn |
| Jun 30, 2024 | 24.06 Mn |
| Mar 31, 2024 | 8.57 Mn |
| Dec 31, 2023 | 38.67 Mn |
| Sep 30, 2023 | -7.42 Mn |
| Jun 30, 2023 | 16.67 Mn |
| Mar 31, 2023 | 1.97 Mn |
| Dec 31, 2022 | -11.19 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 6.75 Mn |
| Mar 31, 2022 | -23.50 Mn |
| Dec 31, 2021 | 7.01 Mn |
| Sep 30, 2021 | -42.37 Mn |
| Jun 30, 2021 | 18.98 Mn |